NYSE International 100
8.163,42
PKT
-45,56
PKT
-0,55
%
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.01.24 | UBS Outperform | RBC Capital Markets | |
| 11.01.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 10.01.24 | Diageo Underperform | RBC Capital Markets | |
| 10.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 10.01.24 | Philips Sell | UBS AG | |
| 10.01.24 | GSK Buy | Deutsche Bank AG | |
| 10.01.24 | SAP Buy | UBS AG | |
| 10.01.24 | ING Group Buy | UBS AG | |
| 10.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | ING Group Sector Perform | RBC Capital Markets | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | Siemens Outperform | Bernstein Research | |
| 09.01.24 | Mercedes-Benz Group (ex Daimler) Outperform | Bernstein Research | |
| 09.01.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 09.01.24 | GSK Equal Weight | Barclays Capital | |
| 09.01.24 | Siemens Outperform | Bernstein Research | |
| 09.01.24 | GSK Sell | UBS AG | |
| 09.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 09.01.24 | Philips Underweight | JP Morgan Chase & Co. | |
| 09.01.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.01.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.01.24 | Diageo Outperform | Bernstein Research | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 08.01.24 | Novartis Neutral | UBS AG | |
| 08.01.24 | Rio Tinto Neutral | UBS AG | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 08.01.24 | Sanofi Overweight | Barclays Capital | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 08.01.24 | Philips Equal-weight | Morgan Stanley | |
| 08.01.24 | HSBC Buy | Jefferies & Company Inc. | |
| 05.01.24 | UBS Outperform | RBC Capital Markets | |
| 05.01.24 | Deutsche Bank Outperform | RBC Capital Markets | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 05.01.24 | Novartis Buy | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | TotalEnergies Overweight | Barclays Capital | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital |